Five-year trend in serum HDL-lipoprotein cholesterol in the Finnish population aged 25–64 years A suggestion of an increase

      This paper is only available as a PDF. To read, Please Download here.


      High density lipoprotein cholesterol (HDLC) was measured in the population surveys carried out in Finland in 1982 and 1987. The mean (± SD) of HDLC for men aged 25–64 years was 1.23 ± 0.32 mmol/l in 1982 and 1.30 ± 0.33 mmol/l in 1987, the increase being 5.7%. Respective values in women were 1.46 ± 0.33 mmol/l and 1.58 ± 0.35 mmol/l, an increase of 8.2%. The increase was significantly greater in women than in men (P < 0.001). The prevalence of low HDLC (≤ 0.9 mmol/1) fell from 13.5 to 9.6% in men and from 3.2 to 1.4% in women. Factors associated with low HDLC were the history of ischemic heart disease (IHD), diabetes and hypertension in both sexes and the positive family history of lHD in women. Subjects with low HDLC also had higher body mass index (BMI), waist-hip ratio and serum total cholesterol (TC) concentration than subjects with normal HDLC. Changes in BMI, waist-hip ratio, alcohol intake, leisure time physical activity, prevalence of smoking or in the dietary variables recorded, did not explain the increase in HDLC.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Jacobs D.R.
        • Mebane I.L.
        • Bangdiwala S.I.
        • Criqui M.N.
        • Tyroler H.A.
        High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: The follow-up study of the Lipid Research Clinics prevalence study.
        Am. J. Epidemiol. 1990; 131: 32
        • Pocock S.J.
        • Shaper A.G.
        • Phillips A.X.
        Concentrations of high density lipoprotein cholesterol, triglycerides, and total cholesterol in ischeamic heart disease.
        Br. Med. J. 1989; 298: 998
        • Abbott R.D.
        • Wilson P.W.F.
        • Kannel W.B.
        • Castelli W.P.
        High Density Lipoprotein Cholesterol, Total Cholesterol Screening, and Myocardial Infarction.
        Arteriosclerosis. 1988; 8: 207
        • Helsinki Heart Study
        Primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia.
        N. Engl. J. Med. 1987; 317: 1237
        • Gordon D.J.
        • Probstfield J.L.
        • Garrison R.J.
        • Neaton J.D.
        • Castelli W.P.
        • Knoke J.D.
        • Jacobs D.R.
        • Bangdiwala S.
        • Tyroler H.A.
        High-density lipoprotein cholesterol and cardiovascular disease.
        Circulation. 1989; 79: 8
        • Linn S.
        • Fulwood R.
        • Rifkind B.
        • Carrol M.
        • Muesing R.
        • Williams O.D.
        • Johnson C.
        High density lipoprotein cholesterol levels among US adults by selected demographic and socioeconomic variables.
        Am. J. Epidemiol. 1989; 129: 281
        • Castelli W.P.
        • Cooper G.R.
        • Doyle J.T.
        • Garcia-Palmieri M.
        • Gordon D.
        • Hanes G.
        • Hulley S.B.
        • Kagan A.
        • Kuchmak M.
        • McGee D.
        • Vicic W.J.
        Distribution of triglyceride and total LDL and HDL cholesterol in several populations: a cooperative lipoprotein phenotyping study.
        J. Chron. Dis. 1977; 30: 147
        • WHO MONICA Project Principal Investigators
        The World Health Organization MONICA Project (Monitoring trends and determinants in cardiovascular disease): a major international collaboration.
        J. Clin. Epidemiol. 1988; 41: 105
        • World Health Organization
        3rd edn. MONICA Manual CVD/MNC/Version 1.1. 1986 (Geneva)
        • Pietinen P.
        • Nissinen A.
        • Vartiainen E.
        • Tuomilehto J.
        • Uusitalo U.
        • Ketola A.
        • Moisio S.
        • Puska P.
        Dietary changes in the North Karelia project (1972–1982).
        Prev. Med. 1988; 17: 183
        • Röschlau P.
        • Bernt E.
        • Gruber W.
        Enzymatische Bestimmung des Gesamtcholesterins in Serum.
        Z. Klin. Biochem. 1974; 12: 226
        • Salomaa V.
        • Korhonen H.J.
        • Tuomilehto J.
        • Vartiainen E.
        • Pietinen P.
        • Kartovaara L.
        • Gref C.-G.
        • Nissinen A.
        • Puska P.
        Serum cholesterol distribution, measurement frequency and cholesterol awareness in three geographical areas of Finland.
        Eur. Heart. J. 1990; 11: 294
        • Köstner G.M.
        Enzymatic determination of cholesterol in high density lipoprotein fraction prepared by polyanion precipitation.
        Clin. Chem. 1976; 22: 695
        • The Committee on Enzymes of the Scandinavian Society for Clinical Chemistry and Clinical Physiology
        Recommended method for the determination of gamma-glutamyltransferase in blood.
        Scand. J. Clin. Lab. Invest. 1976; 36: 119
        • SPSS
        Statistical package of the social sciences. SPSS-X.
        3rd edn. SPSS Inc, Chicago, IL1988
        • Superko H.R.
        • Bachorik P.S.
        • Wood P.D.
        High-density hpoprotein cholesterol measurements. A help or hindrance in practical clinical medicine?.
        J. Am. Med. Assoc. 1986; 236: 2714
        • Grundy S.M.
        • Goodman D.S.
        • Rifkind B.M.
        • Cleeman J.I.
        The place of HDL in cholesterol management. A perspective from the National Cholesterol Education Program.
        Arch. Intern. Med. 1989; 149: 505
        • Del Gatto L.
        • Nichols A.V.
        • Lindgren F.T.
        Effects of freeze-thawing and storage on ultracentrifugal properties of human serum lipoproteins.
        in: 5th Edition. Proc. Soc. Exp. Biol. Med.101. 1959: 59
        • Bachorik P.S.
        • Walker R.
        • Brownell K.D.
        • Stunkard A.J.
        • Kwiterovich P.O.
        Determination of high density lipoprotein-cholesterol in stored human plasma.
        J. Lipid. Res. 1980; 21: 608
        • Folsom A.R.
        • Kuba K.
        • Luepker R.V.
        • Jacobs D.R.
        • Frants Jr., I.D.
        Lipid concentrations in serum and EDTA-treated plasma from fasting and nonfasting normal persons, with particular regard to high-density lipoprotein cholesterol.
        Clin. Chem. 1983; 29: 505
        • Groot P.H.E.
        • Scheek L.M.
        Effects of fat ingestion on high density lipoprotein profiles in human sera.
        J. Lipid. Res. 1984; 25: 684
        • Cohn J.S.
        • McNamara J.R.
        • Schaefer E.J.
        Lipoprotein cholesterol concentrations in the plasma of human subjects as measured in the fed and fasted states.
        Clin. Chem. 1988; 34: 2456
        • Kashyap M.L.
        • Barnhart R.L.
        • Srivastava L.S.
        • Perisutti G.
        • Allen C.
        • Hogg E.
        • Glueck C.J.
        • Jackson R.L.
        Alimentary lipemia: plasma high-density lipoproteins and apolipoproteins CII and CIII in healthy subjects.
        Am. J. Clin. Nutr. 1983; 37: 233
        • Austin M.A.
        Plasma triglyceride as a risk factor for coronary heart disease.
        Am. J. Epidemiol. 1989; 129: 249
      1. Food Balance Sheets. Agricultural Economics Research Institute, Helsinki, Finland.

        • National Cholesterol Education Program
        Highlight of the Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults.
        NIH Publication No. 88-2926. November 1987;
        • European Atherosclerosis Society
        • Study Group
        The recognition and management of hyperlipidaemia in adults: a policy statement of the European Atherosclerosis Society.
        Eur. Heart. J. 1988; 9: 571
        • Quensel M.
        • Söderström A.
        • Agardh C.D.
        • Nilsson-Ehle P.
        High density lipoprotein concentrations after cessation of smoking: the importance of alterations in diet.
        Atherosclerosis. 1989; 75: 189
        • Stubbe I.
        • Eskilsson J.
        • Nilsson-Ehle P.
        High-density lipoprotein concentrations increase after stopping smoking.
        Br. Med. J. 1982; 284: 1511
        • Tuonulehto J.
        • Tanskanen A.
        • Salonen I.T.
        • Nissinen A.
        • Koskela K.
        Effects of smoking and stopping smoking on serum high-density lipoprotein cholesterol levels in a representative population sample.
        Prev. Med. 1986; 15: 35
        • Fraser G.E.
        • Babaali H.
        Determinants of high density lipoprotein cholesterol in middle-aged seventh-day Adventist men and their neighbors.
        Am. J. Epidemiol. 1989; 130: 958
        • Pocock S.J.
        • Shaper A.G.
        • Phillips A.N.
        • Walker M.
        • Whitehead T.P.
        High density lipoprotein cholesterol is not a major risk factor for ischaemic heart disease in British men.
        Br. Med. J. 1986; 292: 515
        • Keys A.
        • Karvonen M.J.
        • Punsar S.
        • Menotti A.
        • Fidanza F.
        • Farchi G.
        HDL Serum cholesterol and 24-year mortality of men in Finland.
        Int. J. Epidemiol. 1984; 13: 428
        • Manninen V.
        • Elo O.
        • Frick H.
        • Hapa K.
        • Heinonen O.P.
        • Heinsalmi P.
        • Helo P.
        • Huttunen J.K.
        • Kaitaniemi P.
        • Koskinen P.
        • Mäenpää H.
        • Mälkönen M.
        • Mänttäri M.
        • Norola S.
        • Pasternack A.
        • Pikkarainen J.
        • Rond M.
        • Sjöblom T.
        • Nikkilä E.A.
        Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study.
        J. Am. Med. Assoc. 1988; 260: 641